Patient-controlled epidural analgesia after TKA was associated with reduced postoperative pain but had no effect on postoperative nausea and vomiting incidence.

The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...

On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...

AlgoTherapeutix blames a “strong placebo effect” for the mid-stage failure for its pain gel ATX01, but the company still ...

Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management an ...